This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Shigetomo Tsujihata
Senior Scientist, Bio Science & Engineering Laboratory at FUJIFILM Corporation


Shigetomo Tsujihata joined Fujifilm Corporation in 2000 and have been involved in R&D related to nanoparticle formulation and dispersion. He has more than 10 years of experience in nano-DDS, with a particular focus on lipid nanoparticles. He manages CDMO projects on LNPs and his team is responsible for molecular design of ionizable lipids, formulation of LNPs, and process development.

Agenda Sessions

  • Novel Ionizable Lipids and Their LNPs to Accelerate Development of RNA based Therapeutics